Miriam Merad, Director of the Precision Immunology Institute at Icahn School of Medicine at Mount Sinai, shared on X:
“Excited to share our new study Science Magazine by the fantastic Raphael Mattiuz and Jesse Boumelha, showing how DC build and sustain tertiary lymphoid structures in cancer. A major step toward enhancing anti-tumor immunity.
Many thanks to our colleagues for their intellectual insights, collaboration and generosity Nikhil, Kamphorst Lab, Tullia Bruno, Hélène Salmon – It was a pleasure working with you all.”
Title: Dendritic cells control tertiary lymphoid structure development and maintenance in cancer
Authors: Raphaël Mattiuz, Jesse Boumelha, Emmanouil Aerakis, Jessica Le Berichel, Pauline Hamon, Laszlo Halasz, Abishek Vaidya, Brian Y. Soong, Emir Radkevich, Miriam Merad
Read the full article.
To which Samarth Hegde, Assistant Professor at Albert Einstein College of Medicine, added:
“Contributed to this tour-de-force from my friends Raphael and Jesse Boumelha! Look at that author list which tells you all about the deep collaborations that made this happen. Miriam Merad
lab at the forefront of studying how TLS formation can be used to develop next gen Tx.”
Other articles about tertiary lymphoid structures on OncoDaily.
